Curis biotechnologies LLP was founded in early 2017 with a vision to provide better healthcare options in Oncology as well as Critical Care segment of Pharmaceutical Industry.
CURIS BIOTECH is headed by Mr. Anandhasaynam Aravamuthan who has 22 years of diverse & rich experience of working in pharmaceutical industry especially in Oncology & Critical Care division. He has worked for leading Indian companies like Unimark Remedies, Ozone Pharma, Basikos Pharma etc
To be a leading pharmaceutical company in India as well as a global entity in international pharmaceutical market by providing high quality, affordable and innovative healthcare solutions and by
By this we intend to enhance the lives of fellow human beings by helping them overcome demanding and challenging health situations with quality products.
All our products are being manufactured ensuring strict compliance with WHO-GMP guidelines, prevailing national & international standards in accordance with the pharmaceutical industry.
At CURIS, quality comes first and it is a commitment that overrides all other considerations. Strict quality control procedures are maintained at every step starting from sourcing of API to the dispatch of FF.
By going with the export vision of CURIS, a dedicated export regulatory team has been set up for complying with the international audits and providing complete export documentation including COPP and dossier preparations as per CTD, ACTD, eCTD format.
Service and quality are the common feature of both the medical fraternity and CURIS and we always aim high to provide high quality medicines to the society and quality of life for millions with the help of medical fraternity.
In short,
THE MORE YOU SUPPORT CURIS,
THE MORE YOU SUPPORT OUR SOCIETY.
Every product, every service, every policy & every person in CURIS contribute to the quality and so “QUALITY IS OUR DAILY ROUTINE”.
You are the only qualified professional, who can bring in this change and so, WE NEED YOUR SUPPORT TO SUPPORT OUR SOCIETY.
